Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$115.41

-3.08 (-2.60%)

08:06
10/19/16
10/19
08:06
10/19/16
08:06

Johnson & Johnson should be bought on weakness, says Leerink

Leerink analyst Danielle Antalffy believes the recent selloff in Johnson & Johnson's shares was overdone and would recommend buying on weakness. The analyst views the company as well-equipped to manage the inevitable Remicade headwind and continues to believe Johnson & Johnson can drive improving top-line growth in 2017. She reiterates an Outperform rating and $140 price target on the shares.

  • 27

    Oct

  • 06

    Nov

JNJ Johnson & Johnson
$115.41

-3.08 (-2.60%)

09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
09/19/16
LEER
09/19/16
NO CHANGE
LEER
Abbott, Johnson & Johnson transaction positive for both companies, says Leerink
Leerink analyst Danielle Antalffy says the sale of Abbott's (ABT) Medical Optics ophthalmology business to Johnson & Johnson (JNJ) is positive for both companies. The deal strengthens Abbott's balance sheet and eliminates the need for a previously expected $3B capital raise, and adds a key component to Johnson & Johnson's already-strong vision care franchise, the analyst notes.
10/07/16
RBCM
10/07/16
NO CHANGE
RBCM
Johnson & Johnson weakness creates buying opportunity, says RBC Capital
RBC Capital analyst Glenn Novarro says that Johnson & Johnson underperformed the market in Q3 due to a number of factors including Remicade biosimilar risk and the pharma pricing debate. The analyst says that "these concerns are manageable/overblown," and he expects the company to report strong Q3 results, driven by a strong pharma performance. Novoroo expects the company's Q3 revenue to come in slightly above expectations, and he predicts that the company will narrow its 2016 EPS guidance to the high end of the previous range. The analyst recommends buying the stock. He keeps a $133 price target and Outperform rating on the shares.
10/18/16
UBSW
10/18/16
NO CHANGE
Target $137
UBSW
Buy
Johnson & Johnson robust pipeline underappreciated, says UBS
UBS analyst Matt Miksic said the Johnson & Johnson pipeline remains robust and is underappreciated. The analyst said the recent launch of biosimilars removes uncertainty and should be positive for the stock. He also expects the additional deployment of the company's capital - to expand its pipeline through in-licensing, partnerships or mid-sized acquisitions - to be incremental to his Buy thesis. Miksic has a $137 price target on Johnson & Johnson shares.

TODAY'S FREE FLY STORIES

ILG

ILG

$18.88

-0.21 (-1.10%)

15:11
03/01/17
03/01
15:11
03/01/17
15:11
Options
Notable call spread in ILG after earnings were reported yesterday »

Notable call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 15

    Mar

  • 16

    Mar

PRGX

PRGX Global

$6.25

0.45 (7.76%)

15:10
03/01/17
03/01
15:10
03/01/17
15:10
Upgrade
PRGX Global rating change  »

PRGX Global upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDCE

PDC Energy

$67.59

-4.1 (-5.72%)

15:05
03/01/17
03/01
15:05
03/01/17
15:05
Upgrade
PDC Energy rating change  »

PDC Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Apr

  • 20

    Apr

JUNO

Juno Therapeutics

$24.04

0.64 (2.74%)

15:05
03/01/17
03/01
15:05
03/01/17
15:05
Options
Juno Therapeutics options imply 11.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 01

    Apr

SBGI

Sinclair Broadcast

$39.90

-0.05 (-0.13%)

15:01
03/01/17
03/01
15:01
03/01/17
15:01
Hot Stocks
Sinclair Broadcast acquires Tennis Media Company in up to $14M deal »

Sinclair Broadcast Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

PRGX

PRGX Global

$6.25

0.45 (7.76%)

15:01
03/01/17
03/01
15:01
03/01/17
15:01
Upgrade
PRGX Global rating change  »

PRGX Global upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXT

Textron

$49.46

2.16 (4.57%)

15:01
03/01/17
03/01
15:01
03/01/17
15:01
Options
Bullish flow in Textron as shares rally »

Bullish flow in Textron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

NUS

Nu Skin

$49.41

-0.13 (-0.26%)

, EQY

Equity One

$31.20

-0.46 (-1.45%)

14:55
03/01/17
03/01
14:55
03/01/17
14:55
Hot Stocks
Breaking Hot Stocks news story on Nu Skin, Equity One »

Nu Skin to replace Equity…

NUS

Nu Skin

$49.41

-0.13 (-0.26%)

EQY

Equity One

$31.20

-0.46 (-1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REG

Regency Centers

$69.37

-0.98 (-1.39%)

, ENDP

Endo

$13.65

0.36 (2.71%)

14:55
03/01/17
03/01
14:55
03/01/17
14:55
Hot Stocks
Regency Centers to replace Endo in S&P 500 as of 3/2 open »

Regency Centers (REG) is…

REG

Regency Centers

$69.37

-0.98 (-1.39%)

ENDP

Endo

$13.65

0.36 (2.71%)

EQY

Equity One

$31.20

-0.46 (-1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

  • 14

    Mar

ENDP

Endo

$13.65

0.36 (2.71%)

, REG

Regency Centers

$69.37

-0.98 (-1.39%)

14:55
03/01/17
03/01
14:55
03/01/17
14:55
Hot Stocks
Breaking Hot Stocks news story on Endo, Regency Centers »

Endo to replace Regency…

ENDP

Endo

$13.65

0.36 (2.71%)

REG

Regency Centers

$69.37

-0.98 (-1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

  • 14

    Mar

XOP

SPDR Oil Exploration and Production Fund

$38.88

1.0201 (2.69%)

14:51
03/01/17
03/01
14:51
03/01/17
14:51
Options
Hefty put spread in SPDR Oil Exploration and Production ETF »

Hefty put spread in SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNST

Monster Beverage

$41.44

-0.65 (-1.54%)

14:50
03/01/17
03/01
14:50
03/01/17
14:50
Options
Monster Beverage options imply 9.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPXL

Impax

$14.25

-0.4 (-2.73%)

14:45
03/01/17
03/01
14:45
03/01/17
14:45
Downgrade
Impax rating change  »

Impax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 06

    Mar

  • 14

    Mar

14:45
03/01/17
03/01
14:45
03/01/17
14:45
General news
Market remains at record levels in afternoon trading »

Stocks remain sharply…

GD

General Dynamics

$192.22

2.41 (1.27%)

14:43
03/01/17
03/01
14:43
03/01/17
14:43
Hot Stocks
General Dynamics boosts dividend to 84c per share, adds 10M shares to buyback »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$12.26

-0.125 (-1.01%)

, SIRI

Sirius XM

$5.09

-0.09 (-1.74%)

14:41
03/01/17
03/01
14:41
03/01/17
14:41
Periodicals
Liberty Media: Pandora is 'great product,' 'way undermonetized,' Bloomberg says »

Sirius XM (SIRI) CEO…

P

Pandora

$12.26

-0.125 (-1.01%)

SIRI

Sirius XM

$5.09

-0.09 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 06

    Mar

  • 19

    Mar

  • 22

    Mar

  • 23

    Mar

GNW

Genworth

$4.14

0.0501 (1.22%)

14:41
03/01/17
03/01
14:41
03/01/17
14:41
Conference/Events
Genworth to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

GD

General Dynamics

$192.08

2.27 (1.20%)

14:40
03/01/17
03/01
14:40
03/01/17
14:40
Hot Stocks
Breaking Hot Stocks news story on General Dynamics »

General Dynamics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$240.20

3.73 (1.58%)

, SPX

S&P 500

$2,399.94

36.3 (1.54%)

14:38
03/01/17
03/01
14:38
03/01/17
14:38
Technical Analysis
S&P 500 crosses 2400 for the first time »

The S&P 500 (SPX) has…

SPY

SPDR S&P 500 ETF Trust

$240.20

3.73 (1.58%)

SPX

S&P 500

$2,399.94

36.3 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KAR

KAR Auction

$45.02

0.2 (0.45%)

14:33
03/01/17
03/01
14:33
03/01/17
14:33
Hot Stocks
KAR Auction appoints Howse as Chief Commercial Officer »

KAR Auction Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

  • 14

    Mar

  • 15

    Mar

APD

Air Products

$142.94

2.47 (1.76%)

, MPC

Marathon Petroleum

$51.23

1.63 (3.29%)

14:30
03/01/17
03/01
14:30
03/01/17
14:30
Hot Stocks
Air Products says wins additional Marathon Petroleum supply contract »

Air Products (APD)…

APD

Air Products

$142.94

2.47 (1.76%)

MPC

Marathon Petroleum

$51.23

1.63 (3.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

CETX

Cemtrex

$3.54

-0.28 (-7.33%)

14:29
03/01/17
03/01
14:29
03/01/17
14:29
Hot Stocks
Cemtrex announces stock buyback of over 200K shares »

Cemtrex announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCA

MDC Partners

$8.75

-0.1 (-1.13%)

14:27
03/01/17
03/01
14:27
03/01/17
14:27
Hot Stocks
MDC Partners received subpoena from Department of Justice »

MDC Partners disclosed in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

BUD

AB InBev

$109.93

0.44 (0.40%)

, KR

Kroger

$32.09

0.285 (0.90%)

14:26
03/01/17
03/01
14:26
03/01/17
14:26
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BUD

AB InBev

$109.93

0.44 (0.40%)

KR

Kroger

$32.09

0.285 (0.90%)

BURL

Burlington Stores

$87.24

-1.77 (-1.99%)

JOY

Joy Global

$28.20

0.005 (0.02%)

ANF

Abercrombie & Fitch

$11.25

-0.51 (-4.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 02

    Mar

  • 07

    Mar

  • 19

    Mar

14:25
03/01/17
03/01
14:25
03/01/17
14:25
General news
Treasury Action: yields remained elevated »

Treasury Action: yields…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.